Will the FDA approve any psychedelic substance for medical use this year?
2.0% (24h)Health & MedicineOne-Off5mo
KalshiVérifier la disponibilitéKYC requis2% de fraisDonnées de résolution vérifiéesGrossièrement calibréProbabilité implicite actuelleOui 42%+2.0%
Qualite du marche
56 / 100
Qualité moyenneVolume 24h
201,5 €
Liquidité
75,2 k €
Liquidité élevéeAchat / Vente
38.0% / 42.0%
Spread
10.5%
Spread largeDonnées du marché
Mis à jour il y a 18 minutes
17 juil. 25, 14:001 janv. 27, 4:59
Tendances
Fonds fictifs uniquement, aucun argent réelCeci n'est pas un conseil financier
Résultat choisi
Yes42%
Tendance du volume
$2292 juil.25j de données26 juil.
Marchés Associés
New pandemic in 2026?
6,2 k €Oui: 7%
POLYMARKET
POLYMARKET
Measles cases in 2026?
2,5 k €Above 4000: 39%KALSHI
KALSHI
Hantavirus pandemic in 2026?
2,2 k €Oui: 3%POLYMARKET
POLYMARKET
Ebola pandemic in 2026?
1,7 k €Oui: 4%POLYMARKET
POLYMARKET
When will the FDA reclassify BPC-157 to Category 1?
1,3 k €Before September: 24%KALSHI
KALSHI
When "Will Masking Return"? (widespread mask mandates in the USA)
996,3 €September 2023: 1%MANIFOLD MARKETS
MANIFOLD MARKETSActifs dans ces sujets
Règles
If the FDA approves any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes.
- Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca.
- Important information: For purposes of this Contract:
- The listed substances are illustrative, not exhaustive.
- Approval of any other substance commonly recognized in scientific or FDA documentation as a psychedelic, hallucinogen, or entactogen (for example, psilocin, 5-MeO-DMT, methylone, or 2C-, DOx-, or NBOMe-family compounds) may also satisfy the Payout Criterion.
- "Approval for medical use" means an FDA approval letter for an NDA or BLA authorizing marketing of a drug or biologic for human medical use in the United States, where a listed (or otherwise qualifying) psychedelic substance is an active pharmaceutical ingredient of the approved product.